{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T10:31:53Z","timestamp":1793356313364,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["DUT24MS018"],"award-info":[{"award-number":["DUT24MS018"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["DUT26YG110"],"award-info":[{"award-number":["DUT26YG110"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005047","name":"Natural Science Foundation of Liaoning Province","doi-asserted-by":"publisher","award":["2023-MSBA-018"],"award-info":[{"award-number":["2023-MSBA-018"]}],"id":[{"id":"10.13039\/501100005047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005047","name":"Natural Science Foundation of Liaoning Province","doi-asserted-by":"publisher","award":["2025-MS-023"],"award-info":[{"award-number":["2025-MS-023"]}],"id":[{"id":"10.13039\/501100005047","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.jchromb.2026.125306","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T23:47:09Z","timestamp":1789688829000},"page":"125306","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Unveiling the in vivo fate of albumin-bound paclitaxel nanoparticles by UPLC-MS\/MS based on free, protein bound, and total drug"],"prefix":"10.1016","volume":"1284","author":[{"given":"Yu","family":"Miao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guolei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runyi","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linrui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyu","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiyun","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchromb.2026.125306_bb0005","doi-asserted-by":"crossref","first-page":"6549","DOI":"10.1245\/s10434-022-11375-w","article-title":"Technical standards for cancer surgery: commission on cancer standards 5.3-5.8","volume":"29","author":"Katz","year":"2022","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.jchromb.2026.125306_bb0010","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1158\/1535-7163.MCT-23-0663","article-title":"Proton FLASH radiotherapy ameliorates radiation-induced salivary gland dysfunction and oral mucositis and increases survival in a mouse model of head and neck cancer","volume":"23","author":"Chowdhury","year":"2024","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.jchromb.2026.125306_bb0015","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202419418","article-title":"A PD-L1 siRNA-loaded boron nanoparticle for targeted cancer radiotherapy and immunotherapy","volume":"37","author":"Deng","year":"2025","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jchromb.2026.125306_bb0020","article-title":"Copper-doped polydopamine nanoparticles-mediated GSH\/GPX4-depleted ferroptosis and cuproptosis sensitizes lung tumor to checkpoint blockade immunotherapy","volume":"21","author":"Jiang","year":"2025","journal-title":"Small"},{"key":"10.1016\/j.jchromb.2026.125306_bb0025","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1002\/cncr.33587","article-title":"The ever-increasing importance of cancer as a leading cause of premature death worldwide","volume":"127","author":"Bray","year":"2021","journal-title":"Cancer"},{"key":"10.1016\/j.jchromb.2026.125306_bb0030","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.1021\/acs.langmuir.5c05243","article-title":"Paclitaxel-loaded nanoarchaeosomes: an innovative strategy for targeted breast cancer treatment","volume":"42","author":"Ariraman","year":"2026","journal-title":"Langmuir"},{"issue":"6","key":"10.1016\/j.jchromb.2026.125306_bb0035","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics17060689","article-title":"Synthesis and characterization of poly(lactic-co-glycolic acid)\u2013paclitaxel (PLGA-PTX) nanoparticles evaluated in ovarian cancer models","volume":"17","author":"Dragulska","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jchromb.2026.125306_bb0040","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1200\/JCO.2026.44.2_suppl.359","article-title":"Phase II trial of systemic therapy plus intraperitoneal (IP) paclitaxel (PTX) in gastric\/GEJ cancer peritoneal carcinomatosis (GPC): STOPGAP trial","volume":"44","author":"Senthil","year":"2026","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jchromb.2026.125306_bb0045","doi-asserted-by":"crossref","first-page":"9133","DOI":"10.1002\/cam4.5652","article-title":"Standard versus low-dose nab-paclitaxel in previously treated patients with advanced non-small cell lung cancer: a randomized phase II trial (JMTO LC14-01)","volume":"12","author":"Takeuchi","year":"2023","journal-title":"Cancer Med."},{"key":"10.1016\/j.jchromb.2026.125306_bb0050","doi-asserted-by":"crossref","unstructured":"A. Muley, A. Navale, R. Gupta, R.K. Tekade, \u201cNano-Paclitaxel\u201d Unlocking Potential and Redefining Cancer Chemotherapy, ACS Omega, 10 (2025) 28670\u201328690.","DOI":"10.1021\/acsomega.5c02916"},{"key":"10.1016\/j.jchromb.2026.125306_bb0055","article-title":"Research progress of paclitaxel nanodrug delivery system in the treatment of triple-negative breast cancer","volume":"29","author":"Qiao","year":"2024","journal-title":"Mater Today Bio"},{"key":"10.1016\/j.jchromb.2026.125306_bb0060","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/277665a0","article-title":"Promotion of microtubule assembly in vitro by taxol","volume":"277","author":"Schiff","year":"1979","journal-title":"Nature"},{"key":"10.1016\/j.jchromb.2026.125306_bb0065","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jconrel.2023.02.013","article-title":"Carboxylated paclitaxel prodrug nanofibers for enhanced chemotherapy","volume":"355","author":"Lu","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jchromb.2026.125306_bb0070","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.835616","article-title":"Ayurveda-based botanicals as therapeutic adjuvants in paclitaxel-induced myelosuppression","volume":"13","author":"Saggam","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jchromb.2026.125306_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113386","article-title":"Blockade of CCR5 suppresses paclitaxel-induced peripheral neuropathic pain caused by increased deoxycholic acid","volume":"42","author":"Zhong","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.jchromb.2026.125306_bb0080","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/S0959-8049(01)00171-X","article-title":"Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation","volume":"37","author":"Gelderblom","year":"2001","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.jchromb.2026.125306_bb0085","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0168-3659(02)00320-6","article-title":"A novel controlled release formulation for the anticancer drug paclitaxel (Taxol\u00ae): PLGA nanoparticles containing vitamin E TPGS","volume":"86","author":"Mu","year":"2003","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jchromb.2026.125306_bb0090","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2023.1158749","article-title":"Gelatin-based anticancer drug delivery nanosystems: a mini review","volume":"11","author":"Jiang","year":"2023","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.jchromb.2026.125306_bb0095","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1093\/annonc\/mdl104","article-title":"Abraxane, a novel cremophor-free, albumin-bound particle form of paclitaxel for the treatment of advanced non-small-cell lung cancer","volume":"17","author":"Green","year":"2006","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jchromb.2026.125306_bb0100","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3892\/or.2014.3210","article-title":"Comparative study of the antitumor activity of nab-paclitaxel and intraperitoneal solvent-based paclitaxel regarding peritoneal metastasis in gastric cancer","volume":"32","author":"Kinoshita","year":"2014","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.jchromb.2026.125306_bb0105","doi-asserted-by":"crossref","first-page":"e711","DOI":"10.1016\/j.cllc.2018.05.005","article-title":"A randomized phase III study comparing carboplatin with nab-paclitaxel versus docetaxel for elderly patients with squamous-cell lung cancer: study protocol","volume":"19","author":"Kogure","year":"2018","journal-title":"Clin. Lung Cancer"},{"key":"10.1016\/j.jchromb.2026.125306_bb0110","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1158\/1078-0432.CCR-05-1634","article-title":"Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxel","volume":"12","author":"Desai","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jchromb.2026.125306_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2026.151448","article-title":"Human serum albumin-based polymeric nanoparticles for ratiometric co-encapsulation and co-delivery of palbociclib and tamoxifen citrate for synergistic effect in breast cancer management","volume":"354","author":"Gupta","year":"2026","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jchromb.2026.125306_bb0120","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1329636","article-title":"GP60 and SPARC as albumin receptors: key targeted sites for the delivery of antitumor drugs","volume":"15","author":"Ji","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jchromb.2026.125306_bb0125","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.jconrel.2023.12.057","article-title":"Modulating the tumoral SPARC content to enhance albumin-based drug delivery for cancer therapy","volume":"366","author":"Zheng","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jchromb.2026.125306_bb0130","doi-asserted-by":"crossref","DOI":"10.1002\/smsc.202400153","article-title":"Preclinical development of a genetically engineered albumin-binding nanoparticle of paclitaxel","volume":"4","author":"Saha","year":"2024","journal-title":"Small Sci."},{"key":"10.1016\/j.jchromb.2026.125306_bb0135","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-026-51909-w","article-title":"Protein corona guided albumin-binding paclitaxel nanoparticles for treatment of intracranial tumors","volume":"16","author":"Huo","year":"2026","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jchromb.2026.125306_bb0140","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1486686","article-title":"Formulation-dependent differences in paclitaxel distribution to anatomical sites relevant to chemotherapy-induced peripheral neuropathy","volume":"15","author":"Girdenyt\u0117","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jchromb.2026.125306_bb0145","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1158\/1078-0432.CCR-06-2534","article-title":"130-nm albumin\u2013bound paclitaxel enhances tumor radiocurability and therapeutic gain","volume":"13","author":"Wiedenmann","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jchromb.2026.125306_bb0150","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1158\/1078-0432.CCR-19-2182","article-title":"Ultrasound-mediated delivery of paclitaxel for glioma: a comparative study of distribution, toxicity, and efficacy of albumin-bound versus cremophor formulations","volume":"26","author":"Zhang","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jchromb.2026.125306_bb0155","doi-asserted-by":"crossref","first-page":"19736","DOI":"10.1021\/acsami.1c03065","article-title":"Evidence for delivery of abraxane via a denatured-albumin transport system","volume":"13","author":"Hama","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jchromb.2026.125306_bb0160","article-title":"Albumin-based formononetin nanomedicines for lung injury and fibrosis therapy via blocking macrophage pyroptosis","volume":"20","author":"Ouyang","year":"2023","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.jchromb.2026.125306_bb0165","doi-asserted-by":"crossref","DOI":"10.1002\/smtd.202201061","article-title":"Multiscale multimodal investigation of the intratissural biodistribution of Iron nanotherapeutics with single cell resolution reveals co-localization with endogenous Iron in splenic macrophages","volume":"7","author":"Balfourier","year":"2023","journal-title":"Small Methods"}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023226003958?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023226003958?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T09:32:17Z","timestamp":1793352737000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570023226003958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":33,"alternative-id":["S1570023226003958"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2026.125306","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unveiling the in vivo fate of albumin-bound paclitaxel nanoparticles by UPLC-MS\/MS based on free, protein bound, and total drug","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2026.125306","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"125306"}}